Nutritional neuroprotection: Improve neuropathy outcomes

There is an opportunity for chiropractors to adopt a more proactive role treating neuropathy by integrating regenerative technologies with targeted nutritional strategies to support nerve health at a cellular level.

Peripheral neuropathy is no longer a condition encountered only in neurology clinics or late-stage diabetic care. Chiropractors are seeing these patients every day, often before a formal diagnosis has been made. Burning feet, numbness, tingling, balance instability, gait changes and the familiar description of “walking on glass” are increasingly common presentations in conservative musculoskeletal practice.

Despite this prevalence, neuropathy remains under-recognized and frequently undertreated in chiropractic settings.

Photobiomodulation (PBM) and radial pressure wave therapy have emerged as valuable tools in neuropathy care, improving microcirculation, modulating pain signaling and supporting nerve repair.^1,2 However, clinical outcomes are most consistent when these modalities are paired with evidence-based nutritional interventions designed to address the metabolic and neurochemical contributors to peripheral nerve dysfunction.

Video transcript (PDF)

Why neuropathy responds better to a multimodal approach

Peripheral neuropathy is rarely the result of a single pathological process. In clinical practice, it reflects a convergence of metabolic dysregulation, oxidative stress, microvascular compromise and impaired axonal repair. This multifactorial nature explains why single-modality treatments, whether pharmacologic or procedural, often produce incomplete or transient relief.

Photobiomodulation addresses several of these underlying mechanisms by improving mitochondrial efficiency, increasing adenosine triphosphate (ATP) production, enhancing nitric oxide-mediated vasodilation and modulating inflammatory signaling within peripheral nerves.³ Near-infrared and infrared wavelengths stimulate cytochrome c oxidase activity, supporting Schwann cell proliferation and myelin repair while reducing oxidative stress.

Radial pressure wave therapy complements these effects through mechanotransduction. By increasing local perfusion, stimulating angiogenesis and influencing nociceptive signaling through effects on calcitonin gene-related peptide (CGRP) and substance P, shockwave therapy helps restore a more favorable neurovascular and regenerative environment around compromised nerves.^4,5

What neither modality fully resolves on its own is the biochemical substrate support required for sustained nerve recovery. This is where targeted nutritional neuroprotection becomes essential.

Foundational nutrients support peripheral nerve health

Several nutritional agents are supported by significant evidence in the management of peripheral neuropathy, particularly when combined with regenerative therapies.

Alpha-lipoic acid (ALA) remains one of the most extensively studied supplements in diabetic peripheral neuropathy. Its antioxidant properties, ability to improve endoneurial blood flow and influence on glucose metabolism make it particularly valuable in metabolically driven neuropathies. Randomized controlled trials demonstrate significant reductions in pain, paresthesia and sensory deficits with ALA supplementation.⁶

Acetyl-L-carnitine (ALCAR) plays a critical role in mitochondrial fatty acid transport and axonal energy metabolism. Clinical trials and systematic reviews report improvements in nerve conduction velocity and meaningful reductions in neuropathic pain, particularly in conditions associated with metabolic stress and mitochondrial dysfunction.⁷

Methylated B vitamins, especially thiamine (B1), pyridoxine (B6) and cobalamin (B12), are essential for myelin synthesis, nerve conduction and DNA methylation. Functional deficiencies may occur even when serum B12 levels appear normal, particularly in patients with diabetes or those taking metformin. Supplementation supports remyelination and may slow progression of sensory loss.⁸

Omega-3 fatty acids further contribute to nerve health by stabilizing neuronal membranes, reducing neuroinflammation and supporting microvascular integrity. Experimental and translational studies demonstrate enhanced nerve regeneration and improved functional recovery following peripheral nerve injury with omega-3 supplementation.⁹

Collectively, these nutrients establish the biochemical environment necessary for laser and shockwave therapies to exert their regenerative effects more effectively in addition to measured deficiencies.

Agmatine: Modulating sensitization and neurovascular signaling

Agmatine represents an emerging adjunct in neuropathy care where oxidative modulation provides more secondary relief. Rather than acting as a direct regenerative agent, agmatine functions primarily as a neuromodulator, influencing pain perception, nitric oxide signaling and neuroinflammatory pathways.

As an endogenous metabolite of arginine, agmatine interacts with N-methyl-D-aspartate (NMDA) receptors and nitric oxide synthase pathways. Preclinical studies demonstrate agmatine attenuates neuropathic pain behaviors and reduces central and peripheral sensitization following nerve injury.¹⁰ Additional research supports its role in modulating excitatory neurotransmission and improving neurovascular signaling.¹¹

Clinically, agmatine appears to reduce heightened nociceptive gain, helping regulate pain responses that often limit patient tolerance to rehabilitation and regenerative interventions, i.e., where compliance is related and of the utmost importance. Reviews of translational and clinical data suggest agmatine may serve as a useful adjunct in multimodal neuropathy programs by supporting pain modulation without direct pharmacologic suppression.¹²

In this context, agmatine does not replace photobiomodulation or shockwave therapy; rather, it supports them by creating a more permissive neurochemical environment for tissue repair and functional recovery.

Why laser, shockwave and nutrition work better together

When combined, these interventions address neuropathy across multiple physiological domains. Photobiomodulation enhances mitochondrial efficiency, tissue oxygenation and inflammatory control. Radial pressure wave therapy improves perfusion, connective tissue compliance, myelin regeneration and neurovascular signaling. Targeted nutritional support stabilizes metabolic function, supports axonal repair and mitigates oxidative injury.

In practice, this integrated approach produces outcomes that extend beyond pain reduction. Patients frequently demonstrate improvements in sensation, balance, gait stability, walking tolerance and sleep quality; these changes directly impact independence and long-term quality of life.

Implications for clinical practice

Neuropathy care does not require chiropractors to become neurologists. It requires recognizing many patients presenting for musculoskeletal complaints are already experiencing early nerve compromise. With appropriate screening, regenerative modalities and evidence-based nutritional strategies, chiropractors can intervene earlier in the disease process, before irreversible degeneration occurs.

This approach also aligns with patient expectations. Increasingly, individuals seek non-pharmacologic solutions that improve function rather than merely suppress symptoms. Programs integrating laser therapy, shockwave therapy and nutritional neuroprotection naturally fit within comprehensive care models while delivering measurable clinical value.

Final thoughts

Peripheral neuropathy is complex, multifactorial and increasingly common, but it is not overly complicated. When chiropractors combine photobiomodulation, radial pressure wave therapy and targeted nutritional neuroprotection, they move beyond symptom management toward meaningful functional restoration.

This multimodal strategy reflects the future of conservative neuropathy care: regenerative, evidence-based and clinically practical. Most importantly, it is an approach chiropractors can implement, starting with the patients they are already seeing. 

Christopher M. Prolux, DC, PHD(ABD), CSCS, is a chiropractor and sport scientist with advanced training in clinical neuroscience, exercise physiology and conservative sports medicine. He has authored peer-reviewed articles and lectures nationally on therapeutic technology integration, injury recovery models and evidence-based rehabilitation. Proulx is currently the vice president of clinical affairs and strategy for Medray Laser and Technology.

References

1. Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-361. https://pubmed.ncbi.nlm.nih.gov/28748217/ . Accessed January 23, 2026.
2. Basford JR, et al. Laser therapy: A randomized, controlled trial of the effects of low-intensity Nd:YAG laser irradiation on musculoskeletal back pain. Arch Phys Med Rehabil. 1999;80(6):647-652. https://pubmed.ncbi.nlm.nih.gov/10378490/. Accessed January 23, 2026.
3. Farivar S, et al. Biological effects of low-level laser therapy. J Lasers Med Sci. 2014;5(2):58-62. https://pmc.ncbi.nlm.nih.gov/articles/PMC4291815/. Accessed January 22, 2026.
4. Hausner T, et al. Extracorporeal shock wave therapy promotes peripheral nerve regeneration after sciatic nerve injury. Muscle Nerve. 2012;46(4):463-470. https://pubmed.ncbi.nlm.nih.gov/22575596/. Accessed January 23, 2026.
5. Notarnicola A, Moretti B. Extracorporeal shockwave therapy on diabetic foot ulcers: Clinical outcome and histological findings. BMC Musculoskelet Disord. 2012;13:158. https://pubmed.ncbi.nlm.nih.gov/23738271/. Accessed January 23, 2026.
6. Ziegler D, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A multicenter randomized controlled trial (ALADIN III Study). Diabetes Care. 2006;29(11):2365-2370. https://pubmed.ncbi.nlm.nih.gov/10480774/ . Accessed January 23, 2026.
7. Li S, et al. Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10(3):e0119479. https://pmc.ncbi.nlm.nih.gov/articles/PMC4353712/. Accessed January 23, 2026.
8. Stein J, et al. Association between neuropathy and B-vitamins: A systematic review and meta-analysis. Eur J Neurol. 2021;28:2054-2064. https://doi.org/10.1111/ene.14786. Accessed January 23, 2026.
9. Gladman SJ, Huang W, Lim SN, et al. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids. J Neurochem. 2012;121(5):795-806. https://pubmed.ncbi.nlm.nih.gov/22238091/. Accessed January 23, 2026.
10. Fairbanks CA, Schreiber KL, Brewer KL, et al. Agmatine reverses pain induced by inflammation, neuropathy and spinal cord injury. Proc Natl Acad Sci USA. 2000;97(19):10584-10589. https://pmc.ncbi.nlm.nih.gov/articles/PMC27068/. Accessed January 23, 2026.
11. Kosonen R, et al. Role of agmatine in the application of neural progenitor cell in central nervous system diseases: Therapeutic potentials and effects. Anat Cell Biol. 2021;54(2):143-151. https://pmc.ncbi.nlm.nih.gov/articles/PMC8225474/. Accessed January 23, 2026.
12. Piletz JE, Aricioglu F, Cheng JT, et al. Agmatine: Clinical applications after 100 years in translation. CNS Drugs. 2013;18(17-18):880-893. https://pubmed.ncbi.nlm.nih.gov/23769988/. Accessed January 23, 2026.